Blepharospasm (BSP) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Blepharospasm (BSP) Market Outlook Thelansis’s “Blepharospasm (BSP) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Blepharospasm (BSP) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Blepharospasm (BSP) Overview Blepharospasm (BSP) is a type of focal dystonia characterized by spasms of the eyelids, involuntary closure of the eye, increased spontaneous blinking, or any combination of the previous ones. Patients may initially experience mild and infrequent spasms. However, as symptoms progress, patients may experience visual disability and social withdrawal within 6 months to 3 years, significantly impacting their quali...